Michael Gilkey, MS, MBA is an independent consultant and has held leadership positions from Director to CEO. Michael Gilkey has been responsible for commercial and economic development for the Trailhead Biosystems and the National Center for Regenerative Medicine with the end result of identifying new strategic partners, creating joint projects, starting sponsored research agreements and building closer relationships with current corporate partners. He has been responsible for the development and execution of organizational strategy, planning and completion of both external and internal marketing efforts, commercializing member technology through institutional technology transfer offices, and providing administrative and operational support for its members. He has coordinated various oversight committees and interacted with partner institutions to create multi-institutional grants and training programs, aid clinical research endeavors, and interface with government relations groups to positively influence new policy. Mr. Gilkey also helped create and grow many start-up companies; Antria, LLC, Cleveland Cord Blood Center, Gilkey Biotechnology Consulting, LLC, and Invenio Therapeutics, Inc. Gilkey Biotechnology Consulting was created in 2007 and provides contract services for business planning and strategy, proforma creation, raising financial capital, grant writing, marketing strategy, and creative design.